M C Copin Selected Research

LNH 87 protocol

3/2001

Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M C Copin Research Topics

Disease

8	Neoplasms (Cancer) 02/2014 - 03/2000
3	Carcinoma (Carcinomatosis) 10/2001 - 08/2000
2	Mesothelioma 01/2018 - 02/2014
2	Infections 12/2008 - 03/2000
2	Lymphoma (Lymphomas) 04/2007 - 03/2001
2	Hodgkin Disease (Hodgkin's Disease) 04/2007 - 03/2001
2	Adenocarcinoma 01/2007 - 03/2001
2	Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar) 10/2001 - 03/2001
1	Rare Diseases (Rare Disease) 02/2014
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2008
1	Reinfection 12/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2008
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2008
1	Hyperplasia 04/2007
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2007
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 04/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2004
1	Hypertension (High Blood Pressure) 01/2004
1	Renal Insufficiency (Renal Failure) 01/2004
1	Proteinuria 01/2004
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2001
1	Ulcer 10/2001
1	Crohn Disease (Crohn's Disease) 10/2001
1	Solitary Fibrous Tumors 04/2001
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2001
1	Adenocarcinoma of Lung 03/2001
1	Fibrosarcoma 01/2001
1	Carcinogenesis 01/2001
1	Metaplasia 12/2000
1	Leukemia 05/2000
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2000
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2000
1	renal Oncocytoma 04/2000
1	Renal Cell Carcinoma (Grawitz Tumor) 04/2000
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2000
1	Neoplasm Metastasis (Metastasis) 03/2000

Drug/Important Bio-Agent (IBA)

6	MucinsIBA 01/2007 - 04/2000
2	Keratins (Keratin)IBA 01/2018 - 04/2001
2	AsbestosIBA 02/2014 - 03/2000
2	Proteins (Proteins, Gene)FDA Link 03/2008 - 01/2001
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	Biological ProductsIBA 03/2008
1	Protein Kinase C betaIBA 04/2007
1	Protein Kinase CIBA 04/2007
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2007
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2004
1	Glycoproteins (Glycoprotein)IBA 10/2001
1	Peptides (Polypeptides)IBA 10/2001
1	VimentinIBA 04/2001
1	apomucinIBA 03/2001
1	trkC ReceptorIBA 01/2001
1	Phosphotransferases (Kinase)IBA 01/2001
1	Protein Isoforms (Isoforms)IBA 01/2001
1	Messenger RNA (mRNA)IBA 12/2000
1	StreptavidinIBA 04/2000
1	IronIBA 04/2000
1	Biotin (Vitamin H)FDA Link 04/2000
1	ParaffinIBA 04/2000
1	Keratin-7 (Cytokeratin 7)IBA 04/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2000
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2000
1	Cathepsin BIBA 03/2000
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2000
1	Matrix Metalloproteinases (MMPs)IBA 03/2000
1	Peptide Hydrolases (Proteases)FDA Link 03/2000
1	CathepsinsIBA 03/2000
1	Matrix Metalloproteinase 11IBA 03/2000

Therapy/Procedure

4	Therapeutics 01/2018 - 01/2004
1	Liver Transplantation 12/2008
1	Stem Cell Transplantation 03/2008
1	Peritoneal Dialysis 01/2004
1	LNH 87 protocol 03/2001
1	Nephrectomy 08/2000
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2000
1	Adjuvant Chemotherapy 03/2000
1	Radiotherapy 03/2000